News Industry News Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis May 07, 2019
News Industry News Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device June 25, 2018
News Industry News Essential Medical Inc. Announces CE Mark Approval for the MANTA™ Large Bore Vascular Closure Device July 18, 2016
News Industry News Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device July 08, 2016
News Industry News Essential Medical Inc. Announces Successful Completion of EU Clinical Studies for MANTA™ Large Bore Vascular Closure Device January 31, 2016
News Industry News Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device July 27, 2015
News Industry News Essential Medical Inc. Announces Successful Additional Clinical Studies For MANTA™ Large Bore Vascular Closure Device May 04, 2015
News Industry News Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market June 04, 2014
News Industry News Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections January 27, 2014
News Industry News Intervalve Inc. Receives 510(k) Clearance in the United States for the V8 Aortic Valvuloplasty Balloon Catheter April 26, 2013
News Industry News Loma Vista Medical reports that it is ramping up sales in U.S. and Europe of its FDA-cleared and CE-marked TRUE Dilatation™ Balloon Valvuloplasty Catheter February 12, 2013
News Industry News Loma Vista Medical receives FDA clearance for its TRUE Dilatation™ Balloon Valvuloplasty Catheter October 17, 2012
News Industry News Loma Vista Medical receives CE mark for its TRUE Dilatation™ Balloon Valvuloplasty Catheter May 10, 2012
News Industry News PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery November 09, 2011
News Industry News First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT November 07, 2011